Ryman Healthcare Limited (FRA:RH7)
Germany
· Delayed Price · Currency is EUR 1.099
-0.002 (-0.18%)
Last updated: Jun 26, 2025
Ryman Healthcare Ratios and Metrics
Market cap in millions EUR. Fiscal year is April - March.
Millions EUR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 25, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Market Capitalization | 1,154 | 1,468 | 1,729 | 2,074 | 2,917 | 4,531 | Upgrade
|
| Market Cap Growth | -15.12% | -15.12% | -16.65% | -28.90% | -35.61% | 63.41% | Upgrade
|
| Enterprise Value | 2,029 | 2,836 | 3,109 | 3,818 | 4,454 | 5,812 | Upgrade
|
| Last Close Price | 1.10 | 1.42 | 2.28 | 2.73 | 5.06 | 7.84 | Upgrade
|
| PE Ratio | - | - | - | 13.95 | 6.73 | 17.98 | Upgrade
|
| PS Ratio | 2.90 | 3.69 | 4.53 | 6.19 | 9.17 | 16.70 | Upgrade
|
| PB Ratio | 0.52 | 0.66 | 0.83 | 0.77 | 1.36 | 2.69 | Upgrade
|
| P/TBV Ratio | 0.52 | 0.66 | 0.84 | 0.79 | 1.38 | 2.73 | Upgrade
|
| P/FCF Ratio | 8.64 | 10.99 | 9.27 | 16.43 | 18.54 | 48.61 | Upgrade
|
| P/OCF Ratio | 5.36 | 6.82 | 5.24 | 5.61 | 7.96 | 18.42 | Upgrade
|
| EV/Sales Ratio | 5.17 | 7.13 | 8.15 | 11.39 | 14.00 | 21.42 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | 272.11 | 205.02 | 184.93 | Upgrade
|
| EV/EBIT Ratio | - | - | - | 3810.78 | 1044.34 | 348.33 | Upgrade
|
| EV/FCF Ratio | 15.19 | 21.24 | 16.66 | 30.24 | 28.30 | 62.35 | Upgrade
|
| Debt / Equity Ratio | 0.40 | 0.40 | 0.69 | 0.50 | 0.76 | 0.82 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | 84.83 | 69.96 | 41.93 | Upgrade
|
| Debt / FCF Ratio | 6.72 | 6.72 | 7.67 | 10.73 | 10.40 | 14.80 | Upgrade
|
| Asset Turnover | 0.06 | 0.06 | 0.06 | 0.05 | 0.05 | 0.05 | Upgrade
|
| Inventory Turnover | 626.17 | 626.17 | 83.74 | 26.49 | 17.58 | - | Upgrade
|
| Quick Ratio | 0.01 | 0.01 | 0.02 | 0.14 | 0.69 | 0.78 | Upgrade
|
| Current Ratio | 0.04 | 0.04 | 0.06 | 0.15 | 0.73 | 0.83 | Upgrade
|
| Return on Equity (ROE) | -10.91% | -10.91% | -4.04% | 6.37% | 22.12% | 16.49% | Upgrade
|
| Return on Assets (ROA) | -0.21% | -0.21% | -0.36% | 0.01% | 0.04% | 0.21% | Upgrade
|
| Return on Capital (ROIC) | -0.41% | -0.41% | -0.66% | 0.02% | 0.08% | 0.38% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | - | 0.00% | 0.10% | 0.30% | Upgrade
|
| Earnings Yield | -19.85% | -15.61% | -5.44% | 7.17% | 14.85% | 5.56% | Upgrade
|
| FCF Yield | 11.57% | 9.10% | 10.79% | 6.09% | 5.39% | 2.06% | Upgrade
|
| Dividend Yield | - | - | - | 1.86% | 2.77% | 1.70% | Upgrade
|
| Payout Ratio | - | - | - | 26.41% | 16.16% | 25.41% | Upgrade
|
| Buyback Yield / Dilution | -3.28% | -3.28% | -33.18% | -3.26% | - | - | Upgrade
|
| Total Shareholder Return | - | -3.28% | -33.18% | -1.41% | 2.77% | 1.70% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.